• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, October 6, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Proof of pimple: Mouse model validates how ‘good’ and ‘bad’ bacteria affect acne

Bioengineer by Bioengineer
March 7, 2019
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The novel model mimics human acne and introduces new possibilities for targeted treatments and vaccines

IMAGE

Credit: UC San Diego Health

Researchers have long believed that Propionibacterium acnes causes acne. But these bacteria are plentiful on everyone’s skin and yet not everyone gets acne, or experiences it to the same degree. Genetic sequencing recently revealed that not all P. acnes are the same — there are different strains, some of which are abundant in acne lesions and some that are never found there.

Still, acne research and therapeutic development have been hampered by the lack of an animal model that replicates the human condition. When administered to mice, for example, P. acnes don’t cause long-term skin lesions and the mouse immune system rapidly clears away the bacteria. Now, however, researchers at University of California San Diego School of Medicine, Cedars-Sinai and UCLA have developed a new mouse model that closely resembles human acne by adding one new factor — a synthetic sebum, the waxy skin secretion that increases in human adolescence.

For the first time, the model, described in a paper publishing March 7, 2019 in JCI Insight, allowed the researchers to directly compare “good” (health-associated) and “bad” (acne-associated) strains of P. acnes bacteria in a way that is more relevant to human acne than in previous attempts.

“Since we know exactly which genes differ between these strains, next we can pinpoint exactly what it is about the acne-associated strains that allows them to cause skin lesions,” said George Y. Liu, MD, PhD, professor and chief of the Division of Pediatric Infectious Diseases at UC San Diego School of Medicine. “And that information will help us develop new therapies that specifically block those acne-promoting factors, or tip the balance of a person’s skin chemistry in favor of the healthy strains.”

Liu was a faculty member at Cedars-Sinai at the time of the study.

Liu and team prepared synthetic sebum by following a recipe they found in a previous scientific study, a simple concoction of four ingredients — fatty acid, triglyceride, wax and squalene, a precursor compound to sterols, such as cholesterol and steroid hormones — in ratios that resemble human sebum. (Mice produce skin sebum, too, but its makeup is different.)

“When we started working with these bacteria and checked out the animal models others have been using over the years, we thought ‘we’ve got to come up with something better than this,'” Liu said. “Acne typically occurs when a person hits their teenage years …What’s the difference between a child’s skin and a teenager’s skin? Increased sebum production. And we were surprised to find how such a simple addition made a big difference in our ability to study acne.”

The researchers inoculated mice with P. acnes and applied fresh sebum daily. Without the sebum, the mice had minimal lesions and the bacteria were rapidly cleared from the site of administration. With the sebum alone, there was no effect on the skin.

But when Liu and team applied both sebum and acne-associated strains of P. acnes, they saw what looked like human acne, and the bacteria survived for weeks. These P. acnes strains also caused inflammation in the skin, as measured by elevated levels of inflammatory molecules called cytokines.

Then the researchers tried the same with health-associated strains of P. acnes — strains that aren’t found in human acne lesions. The same amount of bacteria was still present on the skin three days after inoculation, no matter the strain applied. But researchers could clearly see the differences between strains just by looking at the mice, Liu said. Lesions caused by acne-associated P. acnes strains scored approximately two times higher than lesions caused by health-associated strains in a measure that takes into account a lesion’s size, redness, dryness and degree of skin sloughing.

Unlike people, the mice in these experiments were all genetically identical. Liu said that’s important because it means that the differences in acne severity were due only to differences between the bacterial strains, not differences in the mice’s innate ability to react to the bacteria.

Next, the team hopes to improve upon its acne mouse model so they can achieve similar results when the bacteria are applied topically rather than administered by injection under the skin. They also want to study the genes that are unique to acne-associated P. acnes strains and determine what it is about human sebum that promotes these strains.

Liu said this information could help the team better understand who is at increased risk for acne, and how to develop personalized therapies and vaccines that target the acne-promoting bacterial factors or sebum components.

###

Co-authors of this study include: Stacey L. Kolar, Juan Torres, Xuemo Fan, Cedars-Sinai; Chih-Ming Tsai, Cedars-Sinai and UC San Diego; and Huiying Li, UCLA.

Media Contact
Heather Buschman, PhD
[email protected]

Tags: BacteriologyDermatologyGeneticsMedicine/HealthMicrobiologyMolecular BiologyPediatrics
Share13Tweet8Share2ShareShareShare2

Related Posts

Biomolecular Condensates: New Lung Cancer Therapeutic Targets

October 6, 2025

Inflammation, Mutations Impact Colorectal Cancer Immunotherapy Response

October 6, 2025

Investigating Cannabidiol’s Therapeutic Promise in Alzheimer’s Disease

October 6, 2025

Perspectives on Family Involvement in Anorexia Treatment

October 6, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    95 shares
    Share 38 Tweet 24
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    93 shares
    Share 37 Tweet 23
  • Ohio State Study Reveals Protein Quality Control Breakdown as Key Factor in Cancer Immunotherapy Failure

    72 shares
    Share 29 Tweet 18
  • New Insights Suggest ALS May Be an Autoimmune Disease

    71 shares
    Share 28 Tweet 18

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

SLN Biopsy and Prognosis: HER2-Low vs Zero

Brain Structure in 12-Year-Old Preterm Children

Biomolecular Condensates: New Lung Cancer Therapeutic Targets

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 63 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.